Mayo Clinic first to study minibeam radiotherapy in patients with difficult-to-treat cancers | Newswise
Mayo Clinic first to study minibeam radiotherapy in patients with difficult-to-treat cancers | Newswise Newswise
Mayo Clinic first to study minibeam radiotherapy in patients with difficult-to-treat cancers | Newswise Newswise
New Study: Blood Test Shows Promise for Detecting Pancreatic Cancer at Its Earliest Stages City of Hope
Advances in genomic medicine and a deeper understanding of how to harness the immune system continue to allow for more precise therapies that improve outcomes for people with cancer, according to a new report. The American Association for Cancer Research’s Cancer Progress Report 2026 highlights how basic, clinical and…
What it's really like to be on a blood cancer clinical trial: Jane's story Blood Cancer UK
Anixa Biosciences Appoints UPenn's Dr. Carmen Guerra to Cancer Business Advisory Board Yahoo Finance Singapore
Программный сбой: почему рака в России станет больше и чем важны онкоскрининги 360.ru
New AACR report outlines future of cutting-edge cancer research News-Medical
Mayo Clinic first to study minibeam radiotherapy in patients with difficult-to-treat cancers Mayo Clinic News Network
Risk-guided cardioprotection in cardio-oncology Nature
Partner Spotlight: Unlocking the Future of Tumor-Targeted Immunotherapy sanofi.com
ИИ научили вычислять риск летального исхода при раке груди Наука Mail
MAIA Biotechnology Doses First U.S. Patient in Ongoing Phase 2 Non-Small Cell Lung Cancer Clinical Trial The Manila Times
Российский аналог препарата от рака испытают в 40 медцентрах России и клиниках СНГ ФармМедПром
Novel blood test could detect pancreatic cancer at its earliest stages News-Medical
MAIA Biotechnology Doses First U.S. Patient in Ongoing Phase 2 Non-Small Cell Lung Cancer Clinical Trial GlobeNewswire